(Q44612837)

4 December 2017

title

SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients (English)

1 reference

4 December 2017

1 reference

Estrid Høgdall

6

0 references

Ann Tabor

object named as

Ann Tabor

7

0 references

author name string

Sofie Leisby Antonsen

1

1 reference

4 December 2017

Annika Loft

2

1 reference

4 December 2017

Rune Fisker

3

1 reference

4 December 2017

Anne Lerberg Nielsen

4

1 reference

4 December 2017

Erik Søgaard Andersen

5

1 reference

4 December 2017

Kirsten Jochumsen

8

1 reference

4 December 2017

Carsten L Fagö-Olsen

9

1 reference

4 December 2017

Jon Asmussen

10

1 reference

4 December 2017

Anne Kiil Berthelsen

11

1 reference

4 December 2017

Ib Jarle Christensen

12

1 reference

4 December 2017

Claus Høgdall

13

1 reference

4 December 2017

language of work or name

English

0 references

publication date

29 January 2013

1 reference

4 December 2017

1 reference

4 December 2017

volume

129

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

298-303

1 reference

4 December 2017

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

Molecular imaging of cancer with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

FDG PET for the assessment of myometrial infiltration in clinical stage I uterine corpus cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

Patients with atypical hyperplasia of the endometrium should be treated in oncological centers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

Revised FIGO staging for carcinoma of the endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

Biological characterisation of breast cancer by means of PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

Prediction of pathology and survival by FDG PET in gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.01.019

10.1016/J.YGYNO.2013.01.019

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference